In this article Angela Wixey discusses a local programme of work that was established to unravel the risk factors associated with under- and over- diagnosis of COPD. The service was operated by a Respiratory Nurse Specialist (RNS) credited by the Association of Respiratory Technology and Physiology (ARTP) in spirometry who examined 375 patients in five practices across the county over 9 months.
Point-of-care testing of C-reactive protein (CRP) for the acute assessment of worsening symptoms in people known to have COPD can safely reduce the use of antibiotics and could help improve the diagnostic approach towards someone presenting in such a crisis. New high-quality evidence has emerged since the last NICE COPD update and we encourage re-opening and review of the current guideline to enable clinicians and system leaders to understand whether and how to implement this promising diagnostic aid.
Noel Baxter PCRS Policy Lead and Tracey Lonergan PCRS Policy Coordinator.
How can referrers and practitioners who run courses communicate the benefits of PR to patients?
Guidance was published in April 2021 regarding the reinstatement of spirometry services during and post-COVID-19. The guidance aims to minimise risk to patient and healthcare professional. Our Spirometry Q&A may help answer some of your questions.
A video has been produced by Dr Katherine Hickman, Respiratory Lead for West Yorkshire and Harrogate and a GP in Bradford, about managing stable COPD and asthma patients over the phone. Some further videos are in the process of being developed.